000 01592 a2200517 4500
005 20250511205056.0
264 0 _c19920610
008 199206s 0 0 eng d
022 _a0332-5652
040 _aNLM
_beng
_cNLM
100 1 _aHalstensen, A
245 0 0 _aSerum opsonins to serogroup B meningococci after disease and vaccination.
_h[electronic resource]
260 _bNIPH annals
_cDec 1991
300 _a157-65; discussion 166-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBacterial Capsules
650 0 4 _aBacterial Outer Membrane Proteins
_ximmunology
650 0 4 _aBacterial Vaccines
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aClinical Trials as Topic
650 0 4 _aCross Reactions
650 0 4 _aDose-Response Relationship, Immunologic
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aFlow Cytometry
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aLuminescent Measurements
650 0 4 _aMeningococcal Infections
_xblood
650 0 4 _aMeningococcal Vaccines
650 0 4 _aMiddle Aged
650 0 4 _aOpsonin Proteins
_xblood
650 0 4 _aPolysaccharides, Bacterial
_ximmunology
650 0 4 _aSerotyping
650 0 4 _aTime Factors
700 1 _aLehmann, A K
700 1 _aGuttormsen, H K
700 1 _aVollset, S E
700 1 _aBjune, G
700 1 _aNaess, A
773 0 _tNIPH annals
_gvol. 14
_gno. 2
_gp. 157-65; discussion 166-7
999 _c1818653
_d1818653